1 Min Read
June 6 (Reuters) - Novartis Ag
* Novartis drug Tasigna receives EU approval for inclusion of treatment-free remission (TFR) data in product label Source text for Eikon: Further company coverage: (Reporting By Zurich newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.